Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects

Completed · Phase 3

Conditions studied: Healthy

In brief

Amyloid is an abnormal chemical found in the brain of patients with Alzheimer's Disease (AD). The study drug helps produce pictures of amyloid in the brain. The purpose of this study is to determine how well the study drug performs in young healthy subjects.

Key facts

Study ID

NCT01265394

Run by

GE Healthcare

People needed

218

Starts

2010-12-01

Expected to finish

2011-04-01

Last updated by the study team

2013-07-02

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• The subject age is 18 to 40 years.
• The subject has no evidence of thinking or memory problems by medical history.
• The subject has a normal MRI scan.
• The subject's general health is adequate to comply with study procedures.
• The subject is willing and able to participate in all study procedures.

You may not qualify if…

• The subject has received any medical ionizing radiation exposure in the last 12 months (except planar x-ray or head CT).
• The subject has a contraindication for (cannot undergo) MRI.
• The subject has a history of head injury with loss of consciousness.
• The subject has any significant medical, psychiatric or neurological condition that might be associated with brain pathology.
• The subject has a family history of Alzheimer's Disease (AD); more than 1 first-degree relative.

Where it is running

• GE Healthcare — Princeton, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.